Apyx Medical Corp reports results for the quarter ended March 31 - Earnings Summary

Apyx Medical

08/05/2025 14:31

Apyx Medical Corp APYX.OQ reported a quarterly adjusted loss of 10 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -22 cents.  The mean expectation of three analysts for the quarter was for a loss of 12 cents per share. Wall Street expected results to range from -14 cents to -9 cents per share.

Revenue fell 7.9% to $9.43 million from a year ago; analysts expected $9.39 million.

Apyx Medical Corp's reported EPS for the quarter was a loss of 10 cents​.

The company reported a quarterly loss of $4.15 million.

Apyx Medical Corp shares had fallen by 8.8% this quarter and lost 20.9% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 11.6% in the last three months.​

In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "hold"

Wall Street's median 12-month price target for Apyx Medical Corp is $4.00

This summary was machine generated from LSEG data May 8 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
-0.12
-0.10
Beat
Dec. 31 2024
-0.16
-0.12
Beat
Sep. 30 2024
-0.19
-0.14
Beat
Jun. 30 2024
-0.20
-0.19
Beat